Applications are now open !

For ECO2026 EASO will offer a limited number of travel grants to accepted abstract presenters.  Each grant includes complimentary registration for successful applicants and €500 towards travel and accommodation. EASO Travel Grants are only available to EASO members who would otherwise be unable to attend the ECO for financial reasons.

The deadline for receipt of applications is Sunday 11 January 2026 – late applications will NOT be considered.  All applicants will be informed of the EASO Executive Committee decision by email in late February 2026.  Apply using the form below.

To be eligible to apply for an EASO Travel Grant, you must:

  • Have received a PhD within the past five years or MD within the past eight years (of the application deadline date) or;
  • Be working towards a PhD, MD or equivalent
  • Have carried out the majority of your work in Europe
  • Be a member of an EASO affiliated national obesity association
  • Submit an abstract to ECO2026 (this will form part of the assessment)

Guidance for your application

In your application you should justify why you require support to travel to the ECO Congress. Please include also a short description outlining your work and your contributions to the scientific community and field of obesity research.

Please note: If you have received a grant from EASO or attended any EASO residential teaching schools (e.g. Early Career Network, EASO Masterclass) in the past 2 years your application may not be successful.

  • 2026 EASO Travel Grant Application Form

    * Indique un champ obligatoire
  • Supporting Information

  • Work Experience (most relevant and recent)

  • Education and Training (most relevant and recent)

  • N.B: If you do not receive receipt of your application within 48hrs of submission, please contact the EASO Secretariat.

La Fondation Novo Nordisk a apporté son soutien à l'Association européenne pour l'étude de l'obésité (EASO) dans le cadre d'activités de développement du réseau Early Career Network. La Fondation Novo Nordisk n'a exercé aucune influence sur la sélection des lauréats ou l'ordre du jour des réunions.